ACE inhibitory
			
	We recommend
	
				
 
	
	
		
													
							
		 			
 
	
	
		Long-term effect of the triple combination of perindopril, indapamide, and amlodipine on left ventricular hypertrophy in hypertension
A recent open-label interventional study aimed to describe the long-term effect of a fixed triple combination of perindopril, indapamide, and amlodipine compared to a free combination of a RAAS inhibitor, diuretic, and calcium channel blocker on the reduction of left ventricular hypertrophy (LVH) in hypertensive outpatients.
 
			Myths Accompanying Therapy of Arterial Hypertension
					Arterial hypertension is among the most common yet most underestimated diseases in the adult…
			
	
 
			Do ACE Inhibitors Have a Protective Effect in People with COVID-19?
					Although the COVID-19 pandemic has not lasted even a year, a number of studies have already been…
			
	
Articles on this topic
 
			Journal articles A strategy for cardiovascular prevention: that’s what matters!
					Nová pravidla pro management dyslipidemií zveřejněná v září 2019 přinesla nové paradigma pro kardiovaskulární...
			
	
 
			Journal articles Vascular age
					Věk můžeme hodnotit podle mnoha kritérií. Samozřejmě, že objektivním měřítkem je kalendářní věk,...
			
	
 
			Journal articles Perindopril and cardiovascular disease – 25 years of success in cardiology
					Perindopril je dlouhodobě působící lipofilní inhibitor angiotenzin konvertujícího enzymu s jednodenním...
			
	
 
			Journal articles Prescription and dosage of RAAS inhibitors in patients with chronic heart failure in the FAR NHL registry
					Chronické srdeční selhání se sníženou ejekční frakcí levé komory je časté onemocnění se závažnou...
			
	
						
	
					
		
						
		
		
	
			
			Subscribe
		
	
			
	
	
		
Most read on this topic
Journal on this topic
Related topic
		Most read on this topic
- Perindopril and cardiovascular disease – 25 years of success in cardiology
- Vascular age
- A strategy for cardiovascular prevention: that’s what matters!
- Do ACE Inhibitors Have a Protective Effect in People with COVID-19?
- Prescription and dosage of RAAS inhibitors in patients with chronic heart failure in the FAR NHL registry
- Myths Accompanying Therapy of Arterial Hypertension
Journal on this topic
Related topic
 
					 
					